1.7(top 10%)
Impact Factor
1.9(top 10%)
extended IF
121(top 3%)
H-Index
1.7K
authors
6.2K
papers
133.2K
citations
4.9K
citing journals
30.1K
citing authors

Most Cited Articles of Journal of Clinical Psychopharmacology

TitleYearCitations
Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolam1990532
A Canadian Multicenter Placebo-Controlled Study of Fixed Doses of Risperidone and Haloperidol in the Treatment of Chronic Schizophrenic Patients1993512
Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders1997488
Effects of SSRIs on sexual function: a critical review1999478
Validity and Reliability of the Observer??s1990403
Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease2008390
An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder2008384
Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study)2006375
Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis2009353
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study2008335
Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database2002327
The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV1996324
Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system2002317
A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders2000316
Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline1998273
Treatment of social phobia with gabapentin: a placebo-controlled study1999267
Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder2004263
A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition2004257
Modifications of the Serotonin System by Antidepressant Treatments1987255
The status of disulfiram: a half of a century later2006254
Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio2001253
Psychological and pharmacological treatments of social phobia: a meta-analysis2001249
Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene2000249
Buprenorphine treatment of refractory depression1995247
The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression1990242